Accès gratuit
Numéro
Med Sci (Paris)
Volume 20, Numéro 5, Mai 2004
Page(s) 599 - 603
Section Histoire et sciences sociales
DOI https://doi.org/10.1051/medsci/2004205599
Publié en ligne 15 mai 2004
  1. Jauffret M. L’auto-support des usagers de drogues en France, groupes d’entraide et groupe d’intérêt. Documents du Cesames (Centres de recherche psychotropes, santé mentale, société - CNRS-Université René Descartes Paris V), n°6, 2000.
  2. Emmanuelli J. Programmes d’échange de seringues et réduction des risques chez les usagers de drogues dans le monde développé : état des lieux et mise en perspective. Documents du Cesames (Centres de recherche psychotropes, santé mentale, société - CNRS-Université René Descartes Paris V), n°8, 2001.
  3. Drucker E, Lurie P, Wodak A, Alcabes P. Measuring harm reduction : the effects of needle and syringe exchange programs and methadone maintenance on the ecology of HIV. AIDS 1998; 12 (suppl A) :S217–30.
  4. MacGowan RJ, Sterk CE, Long A, et al. New needle and syringe use, and use of needle exchange programmes by street recruited injection drug users in 1993. Int J Epidemiol 1998; 27 : 302–8.
  5. Hartgers C, Buning EC, van Santen GW, et al. The impact of the needle and syringe-exchange programme in Amsterdam on injecting risk behaviour. AIDS 1989; 3 : 571–6.
  6. Benninghoff P, Gervasoni JP, Spencer B, Dubois-Darber F. Characteristics of attenders of low-threshold syringe-exchange centres in Switzerland. Rev Epidemiol Sante Publ 1998; 46 : 205–17.
  7. Guydish J, Bucardo J, Clark G, Bernheim S. Evaluating needle exchange : a description of client characteristics, health status, program utilisation, and HIV risk behaviour. Subst Use Mis 1998; 33 : 1173–96.
  8. Stimson GV, Alldritt L, Dolan K, Donoghoe MC. Syringe exchange schemes for drug users in England and Scotland. Br Med J 1988; 296 : 1717–9.
  9. Emmanuelli J, Lert F, Valenciano M. Caractéristiques sociales, consommations et risques chez les usagers de drogues fréquentant les programmes d’échange de seringues en France. Rapport d’étude conjointe Institut de Veille Sanitaire/Inserm U88, 1999.
  10. Bruneau J, Lamothe F, Franco E, et al. High rates of HIV infections among IDUs participating in needle exchange programs in Montreal : results of a cohort study. Am J Epidemiol 1997; 146 : 994–1002.
  11. Hahn JA, Vranizan KM, Moss AR. Who uses needle exchange ? A study of injection drug users in treatment in San Francisco, 1989–1990. J AIDS Hum Retrovir 1997; 15 : 157–64.
  12. Archibald CP, Ofner M, Strathdee SA, et al. Factors associated with frequent needle exchange program attendance in injection drug users in Vancouver, Canada. J AIDS Hum Retrovir 1998; 17 : 160–6.
  13. Vlahov D. The evaluation of needle exchange programs. Am J Publ Health 1994; 84 : 1889–91.
  14. Kaplan EH, Khoshnood K, Heimer R. A decline in HIV-infected needles returned to New Haven’s needle exchange program : client shift or needle exchange ? Am J Publ Health 1994; 84 : 1991–4.
  15. Desjarlais DC, Marmor M, Paone D, et al. HIV incidence among injecting drug users in New-York City syringe-exchange programs. Lancet 1996; 348 : 987–91.
  16. Hurley SF, Jolley DJ, Kaldor JM. Effectiveness of needle-exchange programmes for prevention of HIV infection. Lancet 1997; 349 :1797–800.
  17. Oliver KJ, Friedman SR, Maynard H, et al. Impact of a needle exchange program on potentially infectious syringes in public places. J Acquir Immune Def Syndr 1992; 5 : 534–5.
  18. Guydish J, Bucardo J, Young M, et al. Evaluating needle exchange : are there negative effects ? AIDS 1993; 7 : 871–6.
  19. Doherty M, Garfein RS, Vlahov D, et al. Discarded needles do not increase soon after the opening of a needle exchange program. Am J Epidemiol 1997; 145 : 730–7.
  20. Frischer M, Taylor A, Goldberg D, Elliott L. Direct evaluation of needle and syringe exchange programmes. Lancet 1996; 347 : 768.
  21. Strathdee S, Ameijden EJC, Mesquita F, et al. Can HIV epidemics among injection drug users be prevented ? AIDS 1998; 12 (suppl A) : S71–9.
  22. Bluthenthal RN, Kral AH, Erringer EA, Edlin BR. Use of an illegal syringe exchange and injection-related risk behaviors among street-recruited injection drug users in Oakland, California, 1992 to 1995. J AIDS Hum Retrovir 1998; 18 : 505–11.
  23. Lamden KH, Kennedy N, Beeching NJ, et al. Hepatitis B and hepatitis C virus infections : risk factors among drug users in Northwest England. J Infect 1998; 37 : 260–9.
  24. Hagan H, McGough JP, Thiede H, et al. Syringe exchange and risk of infection with hepatitis B and C virus. Am J Epidemiol 1999; 149 : 203–13.
  25. Lurie P, Drucker E. An opportunity lost : HIV infections associated with lack of a national needle-exchange programme in the USA. Lancet 1997; 349 : 604–8.
  26. Remis RS, Bruneau J, Hankins CA. Enough sterile syringes to prevent HIV transmission among injection drug users in Montreal ? J AIDS Hum Retrovir 1998; 18 (suppl 1) : S57–9.
  27. Moss AR, Hahn JA. Invited commentary : needle exchange-no help for hepatitis. Am J Epidemiol 1999; 149 : 214–6.
  28. Lindau C, Lieu T, Giang LT. Rising HIV infection in Ho Chi Minh city herald emerging AIDS epidemic in Vietnam. AIDS 1997; 11 : S5-S13.
  29. Bourgois P, Lettiere M, Quesada J. Social misery and the sanctions of substance abuse : confronting HIV risk among homeless heroin addicts in San Francisco. Social Problems 1997; 44 : 155–73.
  30. CDC, HRSA, NIDA, SAMSHA. Medical advice for persons who inject illicit Drugs. HIV Prevention Bulletin. Baltimore : US Department of Health and Human service, 1997.
  31. Hagan H, Thiede H, Weiss N, Hopkins S, Duchin JS, Alexander ER. Sharing of drug preparation equipment as a risk factor for hepatitis C. Am J Publ Health 2001; 91 : 42–6.
  32. Bastos FI, Strathdee SA. Evaluating effectiveness of syringe exchange programs : current issues and future prospects. Soc Sci Med 2000; 51 : 1771–82.
  33. Janssen RS, Satten GA, Stramer SL, et al. New testing strategies to detect early HIV-1 infection for use in incidence estimates and for clinical and prevention purposes. JAMA 1998; 280 : 42–8.
  34. Van Ameijden EJ, Coutinho RA. Maximum impact of HIV prevention measures targeted at injecting drug users. AIDS 1998; 12 : 625–33.
  35. Van Ameijden EJ, van den Hoek JA, Hartgers C, Coutinho RA. Risk factors for the transition from noninjection to injection drug use and accompanying AIDS risk behavior in a cohort of drug users. Am J Epidemiol 1994; 139 : 1153–63.
  36. Neaigus A, Friedman SR, Jose B, et al. High-risk personal networks and syringe sharing as risk factors for HIV infection among new drug injectors. J AIDS Hum Retrovir 1996; 11 : 499–509.
  37. Lert F, Candillier C, Imbert E, Belforte B. Pratiques de protection des usagers de drogues et exposition au risque de transmission du VIH. BEH 1995; 50 : 217–20.

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.